{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:34:00Z","timestamp":1777606440889,"version":"3.51.4"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-68565-7","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T14:20:05Z","timestamp":1724336405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses"],"prefix":"10.1038","volume":"14","author":[{"given":"Andr\u00e9s","family":"L\u00f3pez-Cort\u00e9s","sequence":"first","affiliation":[]},{"given":"Alejandro","family":"Cabrera-Andrade","sequence":"additional","affiliation":[]},{"given":"Gabriela","family":"Echeverr\u00eda-Garc\u00e9s","sequence":"additional","affiliation":[]},{"given":"Paulina","family":"Echeverr\u00eda-Espinoza","sequence":"additional","affiliation":[]},{"given":"Micaela","family":"Pineda-Alb\u00e1n","sequence":"additional","affiliation":[]},{"given":"Nicole","family":"Elsitdie","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Bueno-Mi\u00f1o","sequence":"additional","affiliation":[]},{"given":"Carlos M.","family":"Cruz-Segundo","sequence":"additional","affiliation":[]},{"given":"Julian","family":"Dorado","sequence":"additional","affiliation":[]},{"given":"Alejandro","family":"Pazos","sequence":"additional","affiliation":[]},{"given":"Humberto","family":"Gonz\u00e1les-D\u00edaz","sequence":"additional","affiliation":[]},{"given":"Yunierkis","family":"P\u00e9rez-Castillo","sequence":"additional","affiliation":[]},{"given":"Eduardo","family":"Tejera","sequence":"additional","affiliation":[]},{"given":"Cristian R.","family":"Munteanu","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"68565_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1126\/science.abj6987","volume":"376","author":"S Nurk","year":"2022","unstructured":"Nurk, S. et al. The complete sequence of a human genome. Science 376, 44\u201353 (2022).","journal-title":"Science"},{"key":"68565_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1417","volume":"10","author":"JM Barbarino","year":"2018","unstructured":"Barbarino, J. M., Whirl-Carrillo, M., Altman, R. B. & Klein, T. E. PharmGKB: A worldwide resource for pharmacogenomic information. Wiley Interdiscip. Rev. Syst. Biol. Med. 10, e1417 (2018).","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"68565_CR3","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1373\/clinchem.2014.237016","volume":"61","author":"JC Venter","year":"2015","unstructured":"Venter, J. C., Smith, H. O. & Adams, M. D. The sequence of the human genome. Clin. Chem. 61, 1207\u20131208 (2015).","journal-title":"Clin. Chem."},{"key":"68565_CR4","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"68565_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3389\/fphys.2015.00366","volume":"6","author":"G Kandoi","year":"2015","unstructured":"Kandoi, G., Acencio, M. L. & Lemke, N. Prediction of druggable proteins using machine learning and systems biology: A mini-review. Front. Physiol. 6, 366 (2015).","journal-title":"Front. Physiol."},{"key":"68565_CR6","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S1359-6446(03)02902-7","volume":"8","author":"D Brown","year":"2003","unstructured":"Brown, D. & Superti-Furga, G. Rediscovering the sweet spot in drug discovery. Drug Discov. Today 8, 1067\u20131077 (2003).","journal-title":"Drug Discov. Today"},{"key":"68565_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nbt1273","volume":"25","author":"AC Cheng","year":"2007","unstructured":"Cheng, A. C. et al. Structure-based maximal affinity model predicts small-molecule druggability. Nat. Biotechnol. 25, 71\u201375 (2007).","journal-title":"Nat. Biotechnol."},{"issue":"Suppl","key":"68565_CR8","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.drudis.2011.12.008","volume":"17","author":"I Gashaw","year":"2012","unstructured":"Gashaw, I., Ellinghaus, P., Sommer, A. & Asadullah, K. What makes a good drug target?. Drug Discov. Today 17(Suppl), S24-30 (2012).","journal-title":"Drug Discov. Today"},{"key":"68565_CR9","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nrd.2018.14","volume":"17","author":"TI Oprea","year":"2018","unstructured":"Oprea, T. I. et al. Unexplored therapeutic opportunities in the human genome. Nat. Rev. Drug Discov. 17, 317\u2013332 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"68565_CR10","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","volume":"34","author":"DS Wishart","year":"2006","unstructured":"Wishart, D. S. et al. DrugBank: A comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34, D668\u2013D672 (2006).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR11","doi-asserted-by":"publisher","first-page":"D901","DOI":"10.1093\/nar\/gkm958","volume":"36","author":"DS Wishart","year":"2008","unstructured":"Wishart, D. S. et al. DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 36, D901\u2013D906 (2008).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR12","doi-asserted-by":"publisher","first-page":"13978","DOI":"10.1038\/s41598-018-32264-x","volume":"8","author":"S Guerrero","year":"2018","unstructured":"Guerrero, S. et al. Analysis of racial\/ethnic representation in select basic and applied cancer research studies. Sci. Rep. 8, 13978 (2018).","journal-title":"Sci. Rep."},{"key":"68565_CR13","doi-asserted-by":"publisher","DOI":"10.1200\/PO.23.00398","volume":"8","author":"JM Garc\u00eda-C\u00e1rdenas","year":"2024","unstructured":"Garc\u00eda-C\u00e1rdenas, J. M. et al. Toward equitable precision oncology: Monitoring racial and ethnic inclusion in genomics and clinical trials. JCO Precis. Oncol. 8, e2300398 (2024).","journal-title":"JCO Precis. Oncol."},{"issue":"Suppl 5","key":"68565_CR14","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1186\/1471-2164-11-S5-S9","volume":"11","author":"PR Costa","year":"2010","unstructured":"Costa, P. R., Acencio, M. L. & Lemke, N. A machine learning approach for genome-wide prediction of morbid and druggable human genes based on systems-level data. BMC Genomics 11(Suppl 5), S9 (2010).","journal-title":"BMC Genomics"},{"key":"68565_CR15","doi-asserted-by":"publisher","first-page":"15688","DOI":"10.1038\/s41598-018-33911-z","volume":"8","author":"JL Blanco","year":"2018","unstructured":"Blanco, J. L., Porto-Pazos, A. B., Pazos, A. & Fernandez-Lozano, C. Prediction of high anti-angiogenic activity peptides in silico using a generalized linear model and feature selection. Sci. Rep. 8, 15688 (2018).","journal-title":"Sci. Rep."},{"key":"68565_CR16","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1093\/bioinformatics\/bty451","volume":"34","author":"L Wei","year":"2018","unstructured":"Wei, L., Zhou, C., Chen, H., Song, J. & Su, R. ACPred-FL: A sequence-based predictor using effective feature representation to improve the prediction of anti-cancer peptides. Bioinformatics 34, 4007\u20134016 (2018).","journal-title":"Bioinformatics"},{"key":"68565_CR17","doi-asserted-by":"publisher","first-page":"4093","DOI":"10.1021\/acs.jproteome.7b00477","volume":"16","author":"SG Mart\u00ednez-Arzate","year":"2017","unstructured":"Mart\u00ednez-Arzate, S. G. et al. PTML model for proteome mining of B-cell epitopes and theoretical-experimental study of Bm86 Protein sequences from Colima, Mexico. J. Proteome Res. 16, 4093\u20134103 (2017).","journal-title":"J. Proteome Res."},{"key":"68565_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jtbi.2015.07.038","volume":"384","author":"C Fernandez-Lozano","year":"2015","unstructured":"Fernandez-Lozano, C. et al. Classification of signaling proteins based on molecular star graph descriptors using Machine Learning models. J. Theor. Biol. 384, 50\u201358 (2015).","journal-title":"J. Theor. Biol."},{"key":"68565_CR19","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/minf.201300027","volume":"33","author":"CR Munteanu","year":"2014","unstructured":"Munteanu, C. R. et al. LECTINPred: Web server that uses complex networks of protein structure for prediction of lectins with potential use as cancer biomarkers or in parasite vaccine design. Mol. Inform. 33, 276\u2013285 (2014).","journal-title":"Mol. Inform."},{"key":"68565_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jtbi.2012.10.006","volume":"317","author":"E Fern\u00e1ndez-Blanco","year":"2013","unstructured":"Fern\u00e1ndez-Blanco, E., Aguiar-Pulido, V., Munteanu, C. R. & Dorado, J. Random Forest classification based on star graph topological indices for antioxidant proteins. J. Theor. Biol. 317, 331\u2013337 (2013).","journal-title":"J. Theor. Biol."},{"key":"68565_CR21","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/10611860903046610","volume":"17","author":"M Zhu","year":"2009","unstructured":"Zhu, M. et al. The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network. J. Drug Target. 17, 524\u2013532 (2009).","journal-title":"J. Drug Target."},{"key":"68565_CR22","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13073-014-0057-7","volume":"6","author":"J Jeon","year":"2014","unstructured":"Jeon, J. et al. A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening. Genome Med. 6, 57 (2014).","journal-title":"Genome Med."},{"key":"68565_CR23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.aca.2015.02.032","volume":"871","author":"Z-C Li","year":"2015","unstructured":"Li, Z.-C. et al. Large-scale identification of potential drug targets based on the topological features of human protein-protein interaction network. Anal. Chim. Acta 871, 18\u201327 (2015).","journal-title":"Anal. Chim. Acta"},{"key":"68565_CR24","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1039\/c3mb25438k","volume":"9","author":"G Laenen","year":"2013","unstructured":"Laenen, G., Thorrez, L., B\u00f6rnigen, D. & Moreau, Y. Finding the targets of a drug by integration of gene expression data with a protein interaction network. Mol. Biosyst. 9, 1676\u20131685 (2013).","journal-title":"Mol. Biosyst."},{"key":"68565_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060618","volume":"8","author":"D Emig","year":"2013","unstructured":"Emig, D. et al. Drug target prediction and repositioning using an integrated network-based approach. PLoS ONE 8, e60618 (2013).","journal-title":"PLoS ONE"},{"key":"68565_CR26","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1101\/gr.6888208","volume":"18","author":"L Yao","year":"2008","unstructured":"Yao, L. & Rzhetsky, A. Quantitative systems-level determinants of human genes targeted by successful drugs. Genome Res. 18, 206\u2013213 (2008).","journal-title":"Genome Res."},{"key":"68565_CR27","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nbt1338","volume":"25","author":"MA Yildirim","year":"2007","unstructured":"Yildirim, M. A., Goh, K.-I., Cusick, M. E., Barab\u00e1si, A.-L. & Vidal, M. Drug-target network. Nat. Biotechnol. 25, 1119\u20131126 (2007).","journal-title":"Nat. Biotechnol."},{"key":"68565_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/bioinformatics\/btu624","volume":"31","author":"D-S Cao","year":"2015","unstructured":"Cao, D.-S., Xiao, N., Xu, Q.-S. & Chen, A. F. Rcpi: R\/Bioconductor package to generate various descriptors of proteins, compounds and their interactions. Bioinformatics 31, 279\u2013281 (2015).","journal-title":"Bioinformatics"},{"key":"68565_CR29","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3102\/1076998619832248","volume":"44","author":"J Hao","year":"2019","unstructured":"Hao, J. & Ho, T. K. Machine learning made easy: A review of Scikit-learn package in python programming language. J. Educ. Behav. Stat. 44, 348\u2013361 (2019).","journal-title":"J. Educ. Behav. Stat."},{"key":"68565_CR30","doi-asserted-by":"publisher","first-page":"8515","DOI":"10.1038\/s41598-020-65584-y","volume":"10","author":"A L\u00f3pez-Cort\u00e9s","year":"2020","unstructured":"L\u00f3pez-Cort\u00e9s, A. et al. Prediction of breast cancer proteins involved in immunotherapy, metastasis, and RNA-binding using molecular descriptors and artificial neural networks. Sci. Rep. 10, 8515 (2020).","journal-title":"Sci. Rep."},{"key":"68565_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1109\/TIT.1967.1053964","volume":"13","author":"T Cover","year":"1967","unstructured":"Cover, T. & Hart, P. Nearest neighbor pattern classification. IEEE Trans. Inform. Theory 13, 21\u201327 (1967).","journal-title":"IEEE Trans. Inform. Theory"},{"key":"68565_CR32","doi-asserted-by":"publisher","unstructured":"Mika, S., Ratsch, G., Weston, J., Scholkopf, B. & Mullers, K. R. Fisher discriminant analysis with kernels. In Neural Networks for Signal Processing IX: Proceedings of the 1999 IEEE Signal Processing Society Workshop (Cat. No.98TH8468) 41\u201348 https:\/\/doi.org\/10.1109\/NNSP.1999.788121 (IEEE, 1999).","DOI":"10.1109\/NNSP.1999.788121"},{"key":"68565_CR33","doi-asserted-by":"publisher","unstructured":"Patle, A. & Chouhan, D. S. SVM kernel functions for classification. In 2013 International Conference on Advances in Technology and Engineering (ICATE) 1\u20139 https:\/\/doi.org\/10.1109\/ICAdTE.2013.6524743 (IEEE, 2013).","DOI":"10.1109\/ICAdTE.2013.6524743"},{"key":"68565_CR34","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","volume":"49","author":"P Peduzzi","year":"1996","unstructured":"Peduzzi, P., Concato, J., Kemper, E., Holford, T. R. & Feinstein, A. R. A simulation study of the number of events per variable in logistic regression analysis. J. Clin. Epidemiol. 49, 1373\u20131379 (1996).","journal-title":"J. Clin. Epidemiol."},{"key":"68565_CR35","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2307\/1419730","volume":"76","author":"BW White","year":"1963","unstructured":"White, B. W. & Rosenblatt, F. Principles of neurodynamics: Perceptrons and the theory of brain mechanisms. Am. J. Psychol. 76, 705 (1963).","journal-title":"Am. J. Psychol."},{"key":"68565_CR36","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1109\/TGE.1977.6498972","volume":"15","author":"PH Swain","year":"1977","unstructured":"Swain, P. H. & Hauska, H. The decision tree classifier: Design and potential. IEEE Trans. Geosci. Electron. 15, 142\u2013147 (1977).","journal-title":"IEEE Trans. Geosci. Electron."},{"key":"68565_CR37","doi-asserted-by":"publisher","DOI":"10.1023\/a:1010933404324","volume-title":"Random Forests","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random Forests (Springer Science and Business Media LLC, 2001). https:\/\/doi.org\/10.1023\/a:1010933404324."},{"key":"68565_CR38","doi-asserted-by":"publisher","unstructured":"Chen, T. & Guestrin, C. XGBoost: A scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining - KDD \u201916 785\u2013794 https:\/\/doi.org\/10.1145\/2939672.2939785 (ACM Press, 2016).","DOI":"10.1145\/2939672.2939785"},{"key":"68565_CR39","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0167-9473(01)00065-2","volume":"38","author":"JH Friedman","year":"2002","unstructured":"Friedman, J. H. Stochastic gradient boosting. Comput. Stat. Data Anal. 38, 367\u2013378 (2002).","journal-title":"Comput. Stat. Data Anal."},{"key":"68565_CR40","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1109\/TIT.1968.1054102","volume":"14","author":"G Hughes","year":"1968","unstructured":"Hughes, G. On the mean accuracy of statistical pattern recognizers. IEEE Trans. Inform. Theory 14, 55\u201363 (1968).","journal-title":"IEEE Trans. Inform. Theory"},{"key":"68565_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF00058655","volume":"24","author":"L Breiman","year":"1996","unstructured":"Breiman, L. Bagging predictors. Mach. Learn. 24, 123\u2013140 (1996).","journal-title":"Mach. Learn."},{"key":"68565_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/0470013192.bsa501","volume-title":"Encyclopedia of Statistics in Behavioral Science","author":"I Jolliffe","year":"2005","unstructured":"Jolliffe, I. Principal component analysis. In Encyclopedia of Statistics in Behavioral Science (eds Everitt, B. S. & Howell, D. C.) (Wiley, 2005). https:\/\/doi.org\/10.1002\/0470013192.bsa501."},{"key":"68565_CR43","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082 (2018).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nm.4306","volume":"23","author":"SM Corsello","year":"2017","unstructured":"Corsello, S. M. et al. The Drug Repurposing Hub: A next-generation drug library and information resource. Nat. Med. 23, 405\u2013408 (2017).","journal-title":"Nat. Med."},{"key":"68565_CR45","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nrm2039","volume":"7","author":"NK Tonks","year":"2006","unstructured":"Tonks, N. K. Protein tyrosine phosphatases: From genes, to function, to disease. Nat. Rev. Mol. Cell Biol. 7, 833\u2013846 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"68565_CR46","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/j.1742-4658.2012.08609.x","volume":"280","author":"DL Brautigan","year":"2013","unstructured":"Brautigan, D. L. Protein Ser\/Thr phosphatases\u2014The ugly ducklings of cell signalling. FEBS J. 280, 324\u2013345 (2013).","journal-title":"FEBS J."},{"key":"68565_CR47","doi-asserted-by":"publisher","first-page":"2944","DOI":"10.1021\/acschembio.6b00570","volume":"11","author":"S Fahs","year":"2016","unstructured":"Fahs, S., Lujan, P. & K\u00f6hn, M. Approaches to study phosphatases. ACS Chem. Biol. 11, 2944\u20132961 (2016).","journal-title":"ACS Chem. Biol."},{"key":"68565_CR48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41392-023-01589-z","volume":"8","author":"X Xie","year":"2023","unstructured":"Xie, X. et al. Recent advances in targeting the \u201cundruggable\u201d proteins: From drug discovery to clinical trials. Signal Transduct. Target. Ther. 8, 335 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"68565_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-018-1612-0","volume":"20","author":"D Repana","year":"2019","unstructured":"Repana, D. et al. The Network of Cancer Genes (NCG): A comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens. Genome Biol. 20, 1 (2019).","journal-title":"Genome Biol."},{"key":"68565_CR50","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","volume":"16","author":"NV Chawla","year":"2002","unstructured":"Chawla, N. V., Bowyer, K. W., Hall, L. O. & Kegelmeyer, W. P. SMOTE: Synthetic minority over-sampling technique. JAIR 16, 321\u2013357 (2002).","journal-title":"JAIR"},{"key":"68565_CR51","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0031-3203(96)00142-2","volume":"30","author":"AP Bradley","year":"1997","unstructured":"Bradley, A. P. The use of the area under the ROC curve in the evaluation of machine learning algorithms. Pattern Recogn. 30, 1145\u20131159 (1997).","journal-title":"Pattern Recogn."},{"key":"68565_CR52","doi-asserted-by":"publisher","first-page":"D1302","DOI":"10.1093\/nar\/gkaa1027","volume":"49","author":"D Ochoa","year":"2021","unstructured":"Ochoa, D. et al. Open Targets Platform: Supporting systematic drug-target identification and prioritisation. Nucleic Acids Res. 49, D1302\u2013D1310 (2021).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR53","doi-asserted-by":"publisher","first-page":"W612","DOI":"10.1093\/nar\/gkv352","volume":"43","author":"M Davies","year":"2015","unstructured":"Davies, M. et al. ChEMBL web services: Streamlining access to drug discovery data and utilities. Nucleic Acids Res. 43, W612\u2013W620 (2015).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR54","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47","author":"D Mendez","year":"2019","unstructured":"Mendez, D. et al. ChEMBL: Towards direct deposition of bioassay data. Nucleic Acids Res. 47, D930\u2013D940 (2019).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR55","doi-asserted-by":"publisher","first-page":"D1311","DOI":"10.1093\/nar\/gkaa840","volume":"49","author":"M Ghoussaini","year":"2021","unstructured":"Ghoussaini, M. et al. Open Targets Genetics: Systematic identification of trait-associated genes using large-scale genetics and functional genomics. Nucleic Acids Res. 49, D1311\u2013D1320 (2021).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR56","doi-asserted-by":"publisher","first-page":"D20","DOI":"10.1093\/nar\/gkv1352","volume":"44","author":"CE Cook","year":"2016","unstructured":"Cook, C. E. et al. The European Bioinformatics Institute in 2016: Data growth and integration. Nucleic Acids Res. 44, D20\u2013D26 (2016).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR57","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum, M. J. et al. ClinVar: Improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 46, D1062\u2013D1067 (2018).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR58","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/s41588-019-0528-2","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin, A. R. et al. PanelApp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nat. Genet. 51, 1560\u20131565 (2019).","journal-title":"Nat. Genet."},{"key":"68565_CR59","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","volume":"18","author":"Z Sondka","year":"2018","unstructured":"Sondka, Z. et al. The COSMIC Cancer Gene Census: Describing genetic dysfunction across all human cancers. Nat. Rev. Cancer 18, 696\u2013705 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"68565_CR60","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","volume":"20","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2020","unstructured":"Mart\u00ednez-Jim\u00e9nez, F. et al. A compendium of mutational cancer driver genes. Nat. Rev. Cancer 20, 555\u2013572 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"68565_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13073-018-0531-8","volume":"10","author":"D Tamborero","year":"2018","unstructured":"Tamborero, D. et al. Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations. Genome Med. 10, 25 (2018).","journal-title":"Genome Med."},{"key":"68565_CR62","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.1038\/s41598-018-25076-6","volume":"8","author":"F Iorio","year":"2018","unstructured":"Iorio, F. et al. Pathway-based dissection of the genomic heterogeneity of cancer hallmarks\u2019 acquisition with SLAPenrich. Sci. Rep. 8, 6713 (2018).","journal-title":"Sci. Rep."},{"key":"68565_CR63","doi-asserted-by":"publisher","first-page":"D481","DOI":"10.1093\/nar\/gkv1351","volume":"44","author":"A Fabregat","year":"2016","unstructured":"Fabregat, A. et al. The Reactome pathway Knowledgebase. Nucleic Acids Res. 44, D481\u2013D487 (2016).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR64","doi-asserted-by":"publisher","first-page":"bat025","DOI":"10.1093\/database\/bat025","volume":"2013","author":"D Smedley","year":"2013","unstructured":"Smedley, D. et al. PhenoDigm: Analyzing curated annotations to associate animal models with human diseases. Database 2013, bat025 (2013).","journal-title":"Database"},{"key":"68565_CR65","doi-asserted-by":"publisher","first-page":"D1056","DOI":"10.1093\/nar\/gky1133","volume":"47","author":"D Carvalho-Silva","year":"2019","unstructured":"Carvalho-Silva, D. et al. Open Targets Platform: New developments and updates two years on. Nucleic Acids Res. 47, D1056\u2013D1065 (2019).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR66","doi-asserted-by":"publisher","first-page":"D416","DOI":"10.1093\/nar\/gkz871","volume":"48","author":"M Iannuccelli","year":"2020","unstructured":"Iannuccelli, M. et al. CancerGeneNet: Linking driver genes to cancer hallmarks. Nucleic Acids Res. 48, D416\u2013D421 (2020).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR67","doi-asserted-by":"publisher","first-page":"D631","DOI":"10.1093\/nar\/gkac883","volume":"51","author":"P Lo Surdo","year":"2023","unstructured":"Lo Surdo, P. et al. SIGNOR 3.0, the SIGnaling network open resource 3.0: 2022 update. Nucleic Acids Res. 51, D631\u2013D637 (2023).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR68","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.sbi.2005.06.001","volume":"15","author":"DP Ryan","year":"2005","unstructured":"Ryan, D. P. & Matthews, J. M. Protein-protein interactions in human disease. Curr. Opin. Struct. Biol. 15, 441\u2013446 (2005).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"68565_CR69","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk, D. et al. The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 49, D605\u2013D612 (2021).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23682","volume":"10","author":"MJ Ramos-Medina","year":"2024","unstructured":"Ramos-Medina, M. J. et al. CardiOmics signatures reveal therapeutically actionable targets and drugs for cardiovascular diseases. Heliyon 10, e23682 (2024).","journal-title":"Heliyon"},{"key":"68565_CR71","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: New dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"68565_CR72","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkaa1059","volume":"49","author":"C Mitsopoulos","year":"2021","unstructured":"Mitsopoulos, C. et al. canSAR: Update to the cancer translational research and drug discovery knowledgebase. Nucleic Acids Res. 49, D1074\u2013D1082 (2021).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR73","doi-asserted-by":"publisher","first-page":"D506","DOI":"10.1093\/nar\/gky1049","volume":"47","author":"UniProt Consortium","year":"2019","unstructured":"UniProt Consortium. UniProt: A worldwide hub of protein knowledge. Nucleic Acids Res. 47, D506\u2013D515 (2019).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR74","doi-asserted-by":"publisher","first-page":"eaan2507","DOI":"10.1126\/science.aan2507","volume":"357","author":"M Uhlen","year":"2017","unstructured":"Uhlen, M. et al. A pathology atlas of the human cancer transcriptome. Science 357, eaan2507 (2017).","journal-title":"Science"},{"key":"68565_CR75","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/pro.3307","volume":"27","author":"PJ Thul","year":"2018","unstructured":"Thul, P. J. & Lindskog, C. The human protein atlas: A spatial map of the human proteome. Protein Sci. 27, 233\u2013244 (2018).","journal-title":"Protein Sci."},{"key":"68565_CR76","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/978-1-60761-806-5_12","volume":"664","author":"R Simon","year":"2010","unstructured":"Simon, R., Mirlacher, M. & Sauter, G. Immunohistochemical analysis of tissue microarrays. Methods Mol. Biol. 664, 113\u2013126 (2010).","journal-title":"Methods Mol. Biol."},{"key":"68565_CR77","first-page":"4237","volume":"18","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Identification of potential diagnostic and prognostic biomarkers for prostate cancer. Oncol. Lett. 18, 4237\u20134245 (2019).","journal-title":"Oncol. Lett."},{"key":"68565_CR78","doi-asserted-by":"publisher","first-page":"W191","DOI":"10.1093\/nar\/gkz369","volume":"47","author":"U Raudvere","year":"2019","unstructured":"Raudvere, U. et al. g:Profiler: A web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47, W191\u2013W198 (2019).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR79","doi-asserted-by":"publisher","first-page":"D325","DOI":"10.1093\/nar\/gkaa1113","volume":"49","author":"The Gene Ontology Consortium","year":"2021","unstructured":"The Gene Ontology Consortium. The Gene Ontology resource: Enriching a GOld mine. Nucleic Acids Res. 49, D325\u2013D334 (2021).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR80","doi-asserted-by":"publisher","first-page":"17245","DOI":"10.1038\/s41598-021-96750-5","volume":"11","author":"A L\u00f3pez-Cort\u00e9s","year":"2021","unstructured":"L\u00f3pez-Cort\u00e9s, A. et al. Identification of key proteins in the signaling crossroads between wound healing and cancer hallmark phenotypes. Sci. Rep. 11, 17245 (2021).","journal-title":"Sci. Rep."},{"key":"68565_CR81","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-020-2287-8","volume":"581","author":"RL Collins","year":"2020","unstructured":"Collins, R. L. et al. A structural variation reference for medical and population genetics. Nature 581, 444\u2013451 (2020).","journal-title":"Nature"},{"key":"68565_CR82","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski, K. J. et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434\u2013443 (2020).","journal-title":"Nature"},{"key":"68565_CR83","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/s41586-021-03771-1","volume":"596","author":"F Mui\u00f1os","year":"2021","unstructured":"Mui\u00f1os, F., Mart\u00ednez-Jim\u00e9nez, F., Pich, O., Gonzalez-Perez, A. & Lopez-Bigas, N. In silico saturation mutagenesis of cancer genes. Nature 596, 428\u2013432 (2021).","journal-title":"Nature"},{"key":"68565_CR84","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310\u2013315 (2014).","journal-title":"Nat. Genet."},{"key":"68565_CR85","doi-asserted-by":"publisher","first-page":"D886","DOI":"10.1093\/nar\/gky1016","volume":"47","author":"P Rentzsch","year":"2019","unstructured":"Rentzsch, P., Witten, D., Cooper, G. M., Shendure, J. & Kircher, M. CADD: Predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 47, D886\u2013D894 (2019).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR86","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.08.575577","author":"T Rose","year":"2024","unstructured":"Rose, T., Monti, N., Anand, N. & Shen, T. PLAPT: Protein-ligand binding affinity prediction using pretrained transformers. BioRxiv https:\/\/doi.org\/10.1101\/2024.02.08.575577 (2024).","journal-title":"BioRxiv"},{"key":"68565_CR87","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart, D. S. et al. HMDB 5.0: The human metabolome database for 2022. Nucleic Acids Res. 50, D622\u2013D631 (2022).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR88","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13321-023-00735-7","volume":"15","author":"M Cunningham","year":"2023","unstructured":"Cunningham, M. et al. PINNED: Identifying characteristics of druggable human proteins using an interpretable neural network. J. Cheminform. 15, 64 (2023).","journal-title":"J. Cheminform."},{"key":"68565_CR89","doi-asserted-by":"publisher","first-page":"5694","DOI":"10.3390\/ijms21165694","volume":"21","author":"C Wang","year":"2020","unstructured":"Wang, C. et al. Predicting drug-target interactions with electrotopological state fingerprints and amphiphilic pseudo amino acid composition. Int. J. Mol. Sci. 21, 5694 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"68565_CR90","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.3390\/ijms25084507","volume":"25","author":"H Chu","year":"2024","unstructured":"Chu, H. & Liu, T. Comprehensive research on druggable proteins: From PSSM to pre-trained language models. Int. J. Mol. Sci. 25, 4507 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"68565_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060220","volume":"8","author":"A Vernone","year":"2013","unstructured":"Vernone, A., Berchialla, P. & Pescarmona, G. Human protein cluster analysis using amino acid frequencies. PLoS ONE 8, e60220 (2013).","journal-title":"PLoS ONE"},{"key":"68565_CR92","doi-asserted-by":"publisher","first-page":"14198","DOI":"10.1038\/s41598-023-39401-1","volume":"13","author":"A P\u00e9rez-Villa","year":"2023","unstructured":"P\u00e9rez-Villa, A. et al. Integrated multi-omics analysis reveals the molecular interplay between circadian clocks and cancer pathogenesis. Sci. Rep. 13, 14198 (2023).","journal-title":"Sci. Rep."},{"key":"68565_CR93","doi-asserted-by":"publisher","first-page":"11100","DOI":"10.1038\/s41598-022-15246-y","volume":"12","author":"A L\u00f3pez-Cort\u00e9s","year":"2022","unstructured":"L\u00f3pez-Cort\u00e9s, A. et al. The close interaction between hypoxia-related proteins and metastasis in pancarcinomas. Sci. Rep. 12, 11100 (2022).","journal-title":"Sci. Rep."},{"key":"68565_CR94","doi-asserted-by":"publisher","first-page":"16679","DOI":"10.1038\/s41598-018-35149-1","volume":"8","author":"A L\u00f3pez-Cort\u00e9s","year":"2018","unstructured":"L\u00f3pez-Cort\u00e9s, A. et al. Gene prioritization, communality analysis, networking and metabolic integrated pathway to better understand breast cancer pathogenesis. Sci. Rep. 8, 16679 (2018).","journal-title":"Sci. Rep."},{"key":"68565_CR95","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/s41557-019-0351-5","volume":"11","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs. Nat. Chem. 11, 1113\u20131123 (2019).","journal-title":"Nat. Chem."},{"key":"68565_CR96","doi-asserted-by":"publisher","first-page":"3450","DOI":"10.1038\/s41467-023-39122-z","volume":"14","author":"SM Gross","year":"2023","unstructured":"Gross, S. M. et al. Analysis and modeling of cancer drug responses using cell cycle phase-specific rate effects. Nat. Commun. 14, 3450 (2023).","journal-title":"Nat. Commun."},{"key":"68565_CR97","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41573-021-00195-4","volume":"20","author":"P Cohen","year":"2021","unstructured":"Cohen, P., Cross, D. & J\u00e4nne, P. A. Kinase drug discovery 20 years after imatinib: Progress and future directions. Nat. Rev. Drug Discov. 20, 551\u2013569 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"68565_CR98","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman, A. D., Fritz, J. M. & Lenardo, M. J. A guide to cancer immunotherapy: From T cell basic science to clinical practice. Nat. Rev. Immunol. 20, 651\u2013668 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"68565_CR99","first-page":"275","volume":"2","author":"A Eastman","year":"1990","unstructured":"Eastman, A. Activation of programmed cell death by anticancer agents: Cisplatin as a model system. Cancer Cells 2, 275\u2013280 (1990).","journal-title":"Cancer Cells"},{"key":"68565_CR100","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang, L., Lankhorst, L. & Bernards, R. Exploiting senescence for the treatment of cancer. Nat. Rev. Cancer 22, 340\u2013355 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"68565_CR101","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","volume":"37","author":"AB Hanker","year":"2020","unstructured":"Hanker, A. B., Sudhan, D. R. & Arteaga, C. L. Overcoming endocrine resistance in breast cancer. Cancer Cell 37, 496\u2013513 (2020).","journal-title":"Cancer Cell"},{"key":"68565_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.630658","volume":"12","author":"NM Varela","year":"2021","unstructured":"Varela, N. M. et al. A new insight for the identification of oncogenic variants in breast and prostate cancers in diverse human populations, with a focus on latinos. Front. Pharmacol. 12, 630658 (2021).","journal-title":"Front. Pharmacol."},{"key":"68565_CR103","doi-asserted-by":"publisher","first-page":"585130","DOI":"10.3389\/fendo.2020.585130","volume":"11","author":"V Yumiceba","year":"2020","unstructured":"Yumiceba, V. et al. Oncology and pharmacogenomics insights in polycystic ovary syndrome: An integrative analysis. Front. Endocrinol. 11, 585130 (2020).","journal-title":"Front. Endocrinol."},{"key":"68565_CR104","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3892\/mmr.2016.5414","volume":"14","author":"C Paz-Y-Mi\u00f1o","year":"2016","unstructured":"Paz-Y-Mi\u00f1o, C. et al. Positive association of the androgen receptor CAG repeat length polymorphism with the risk of prostate cancer. Mol. Med. Report. 14, 1791\u20131798 (2016).","journal-title":"Mol. Med. Report."},{"key":"68565_CR105","doi-asserted-by":"publisher","first-page":"1373007","DOI":"10.3389\/fphar.2024.1373007","volume":"15","author":"G Echeverr\u00eda-Garc\u00e9s","year":"2024","unstructured":"Echeverr\u00eda-Garc\u00e9s, G. et al. Gastric cancer actionable genomic alterations across diverse populations worldwide and pharmacogenomics strategies based on precision oncology. Front. Pharmacol. 15, 1373007 (2024).","journal-title":"Front. Pharmacol."},{"key":"68565_CR106","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41397-019-0102-4","volume":"20","author":"A L\u00f3pez-Cort\u00e9s","year":"2020","unstructured":"L\u00f3pez-Cort\u00e9s, A. et al. Pharmacogenomics, biomarker network, and allele frequencies in colorectal cancer. Pharmacogenomics J. 20, 136\u2013158 (2020).","journal-title":"Pharmacogenomics J."},{"key":"68565_CR107","doi-asserted-by":"publisher","first-page":"1175737","DOI":"10.3389\/fphar.2023.1175737","volume":"14","author":"A Salas-Hern\u00e1ndez","year":"2023","unstructured":"Salas-Hern\u00e1ndez, A. et al. An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug\/gene pairs in Latin America and the Caribbean. Front. Pharmacol. 14, 1175737 (2023).","journal-title":"Front. Pharmacol."},{"key":"68565_CR108","doi-asserted-by":"publisher","first-page":"202","DOI":"10.2174\/1389200215666140202220753","volume":"15","author":"LA Quinones","year":"2014","unstructured":"Quinones, L. A. et al. Perception of the usefulness of drug\/gene pairs and barriers for pharmacogenomics in Latin America. Curr. Drug Metab. 15, 202\u2013208 (2014).","journal-title":"Curr. Drug Metab."},{"key":"68565_CR109","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1038\/s41598-020-62279-2","volume":"10","author":"A L\u00f3pez-Cort\u00e9s","year":"2020","unstructured":"L\u00f3pez-Cort\u00e9s, A. et al. OncoOmics approaches to reveal essential genes in breast cancer: A panoramic view from pathogenesis to precision medicine. Sci. Rep. 10, 5285 (2020).","journal-title":"Sci. Rep."},{"key":"68565_CR110","doi-asserted-by":"publisher","first-page":"1381168","DOI":"10.3389\/fphar.2024.1381168","volume":"15","author":"B Oca\u00f1a-Paredes","year":"2024","unstructured":"Oca\u00f1a-Paredes, B. et al. The pharmacoepigenetic paradigm in cancer treatment. Front. Pharmacol. 15, 1381168 (2024).","journal-title":"Front. Pharmacol."},{"key":"68565_CR111","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/s41576-022-00572-8","volume":"24","author":"M Pirmohamed","year":"2023","unstructured":"Pirmohamed, M. Pharmacogenomics: Current status and future perspectives. Nat. Rev. Genet. 24, 350\u2013362 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"68565_CR112","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/ijms18060639","volume":"18","author":"A L\u00f3pez-Cort\u00e9s","year":"2017","unstructured":"L\u00f3pez-Cort\u00e9s, A., Guerrero, S., Redal, M. A., Alvarado, A. T. & Qui\u00f1ones, L. A. State of art of cancer pharmacogenomics in Latin American populations. Int. J. Mol. Sci. 18, 639 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"68565_CR113","doi-asserted-by":"publisher","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","volume":"52","author":"B Zdrazil","year":"2024","unstructured":"Zdrazil, B. et al. The ChEMBL Database in 2023: A drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res. 52, D1180\u2013D1192 (2024).","journal-title":"Nucleic Acids Res."},{"key":"68565_CR114","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.598925","volume":"12","author":"A L\u00f3pez-Cort\u00e9s","year":"2021","unstructured":"L\u00f3pez-Cort\u00e9s, A. et al. In silico analyses of immune system protein interactome network, single-cell RNA sequencing of human tissues, and artificial neural networks reveal potential therapeutic targets for drug repurposing against COVID-19. Front. Pharmacol. 12, 598925 (2021).","journal-title":"Front. Pharmacol."},{"key":"68565_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.606907","volume":"11","author":"M Llaguno-Munive","year":"2021","unstructured":"Llaguno-Munive, M., Vazquez-Lopez, M. I., Jurado, R. & Garcia-Lopez, P. Mifepristone repurposing in treatment of high-grade gliomas. Front. Oncol. 11, 606907 (2021).","journal-title":"Front. Oncol."},{"key":"68565_CR116","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1186\/s12935-021-02306-y","volume":"21","author":"PB Alvarez","year":"2021","unstructured":"Alvarez, P. B. et al. Anticancer effects of mifepristone on human uveal melanoma cells. Cancer Cell Int. 21, 607 (2021).","journal-title":"Cancer Cell Int."},{"key":"68565_CR117","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1158\/1078-0432.CCR-22-2060","volume":"29","author":"A El\u00eda","year":"2023","unstructured":"El\u00eda, A. et al. Beneficial effects of mifepristone treatment in patients with breast cancer selected by the progesterone receptor isoform ratio: Results from the MIPRA trial. Clin. Cancer Res. 29, 866\u2013877 (2023).","journal-title":"Clin. Cancer Res."},{"key":"68565_CR118","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1200\/JCO.1991.9.2.243","volume":"9","author":"PA Cassileth","year":"1991","unstructured":"Cassileth, P. A. et al. Pentostatin induces durable remissions in hairy cell leukemia. J. Clin. Oncol. 9, 243\u2013246 (1991).","journal-title":"J. Clin. Oncol."},{"key":"68565_CR119","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12885-022-10428-3","volume":"23","author":"Y Harada","year":"2023","unstructured":"Harada, Y. et al. Anti-cancer effect of afatinib, dual inhibitor of HER2 and EGFR, on novel mutation HER2 E401G in models of patient-derived cancer. BMC Cancer 23, 77 (2023).","journal-title":"BMC Cancer"},{"key":"68565_CR120","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.107","volume":"2","author":"KZ Htet","year":"2022","unstructured":"Htet, K. Z., Waul, M. A. & Leslie, K. S. Topical treatments for Kaposi sarcoma: A systematic review. Skin Health Dis. 2, e107 (2022).","journal-title":"Skin Health Dis."},{"key":"68565_CR121","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1056\/NEJMoa1802905","volume":"379","author":"JK Litton","year":"2018","unstructured":"Litton, J. K. et al. Talazoparib in patients with advanced breast cancer and a germline BRCA mutation. N. Engl. J. Med. 379, 753\u2013763 (2018).","journal-title":"N. Engl. J. Med."},{"key":"68565_CR122","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","volume":"380","author":"F Andr\u00e9","year":"2019","unstructured":"Andr\u00e9, F. et al. Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer. N. Engl. J. Med. 380, 1929\u20131940 (2019).","journal-title":"N. Engl. J. Med."},{"key":"68565_CR123","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13073-022-01063-5","volume":"14","author":"TE Bartlett","year":"2022","unstructured":"Bartlett, T. E. et al. Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women. Genome Med. 14, 64 (2022).","journal-title":"Genome Med."},{"key":"68565_CR124","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s44276-024-00055-9","volume":"2","author":"A Kumar","year":"2024","unstructured":"Kumar, A. et al. Lorlatinib in the second line and beyond for ALK positive lung cancer: Real-world data from resource-constrained settings. BJC Rep. 2, 35 (2024).","journal-title":"BJC Rep."},{"key":"68565_CR125","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/pros.24527","volume":"83","author":"AT Arafa","year":"2023","unstructured":"Arafa, A. T. et al. Impact of piflufolastat F-18 PSMA PET imaging on clinical decision-making in prostate cancer across disease states: A retrospective review. Prostate 83, 863\u2013870 (2023).","journal-title":"Prostate"},{"key":"68565_CR126","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-073839","volume":"13","author":"FM Ponzini","year":"2023","unstructured":"Ponzini, F. M. et al. Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: Study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma. BMJ Open 13, e073839 (2023).","journal-title":"BMJ Open"},{"key":"68565_CR127","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jb\/mvs041","volume":"152","author":"E Tomitsuka","year":"2012","unstructured":"Tomitsuka, E., Kita, K. & Esumi, H. An anticancer agent, pyrvinium pamoate inhibits the NADH-fumarate reductase system\u2014a unique mitochondrial energy metabolism in tumour microenvironments. J. Biochem. 152, 171\u2013183 (2012).","journal-title":"J. Biochem."},{"key":"68565_CR128","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fonc.2012.00137","volume":"2","author":"I Ishii","year":"2012","unstructured":"Ishii, I., Harada, Y. & Kasahara, T. Reprofiling a classical anthelmintic, pyrvinium pamoate, as an anti-cancer drug targeting mitochondrial respiration. Front. Oncol. 2, 137 (2012).","journal-title":"Front. Oncol."},{"key":"68565_CR129","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.3390\/biomedicines10123249","volume":"10","author":"CW Schultz","year":"2022","unstructured":"Schultz, C. W. & Nevler, A. Pyrvinium pamoate: Past, present, and future as an anti-cancer drug. Biomedicines 10, 3249 (2022).","journal-title":"Biomedicines"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68565-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68565-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68565-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T10:09:19Z","timestamp":1724494159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-68565-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":129,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["68565"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-68565-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19359"}}